Central Pharmaceuticals Ltd. announcements
203 Dhaka Stock Exchange announcements for Central Pharmaceuticals Ltd. (CENTRALPHL) since 2013: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2013 (15).
- Mr. Munsur Ahamed, Ms. Morsheda Ahmed, Mr. Parvez Ahamed Bhuiyan and Ms. Nasima Akter, all are Directors of the Company,
Mr. Munsur Ahamed, Ms. Morsheda Ahmed, Mr. Parvez Ahamed Bhuiyan and Ms. Nasima Akter, all are Directors of the Company, have expressed their intention to sell 17,00,000 shares, 7,00,000 shares, 2,25,000 shares and 60,000 shares (bonus shares) out of their total holdings of 1,32,99,750 shares, 61,29,500 shares, 17,25,000 shares and 14,89,250 shares respectively at prevailing market price through Stock Exchange within next 30 working days.
- Category Change
The Company will be placed in "A" category from existing "N" category with effect from November 27, 2013 as the Company reported disbursement of 15% stock dividend for the year ended on June 30, 2013.
- The Company has informed that it has credited the bonus shares for the year ended on June 30, 2013 to the respective sha
The Company has informed that it has credited the bonus shares for the year ended on June 30, 2013 to the respective shareholders' BO Accounts on November 24, 2013.
- The Company will be placed in "A" category from existing "N" category with effect from November 27, 2013 as the Company
The Company will be placed in "A" category from existing "N" category with effect from November 27, 2013 as the Company reported disbursement of 15% stock dividend for the year ended on June 30, 2013.
- (Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2013 (July'13 to Sep'13), the Com
(Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th September 2013 (July'13 to Sep'13), the Company has reported net profit after tax of Tk. 26.67 million with basic EPS of Tk. 0.43 as against Tk. 13.92 million and Tk. 0.29 respectively for the same period of the previous year. However, considering proposed bonus share @ 15% for the year 2013, restated basic EPS will be Tk. 0.37 as on 30.09.2013 and Tk. 0.24 as on 30.09.2012.
- Normal trading of the shares of the Company will resume on 29.10.2013 after record date.
Normal trading of the shares of the Company will resume on 29.10.2013 after record date.
- Trading of the shares of the Company will remain suspended on record date i.e., 28.10.2013.
Trading of the shares of the Company will remain suspended on record date i.e., 28.10.2013.
- Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 23.10.2013 to 27.10.2013. Trading of the shares of the Company will remain suspended on record date i.e., 28.10.2013.
- The Board of Directors has recommended stock dividend @ 15% for the year ended on June 30, 2013. Date of AGM: 20.11.2013
The Board of Directors has recommended stock dividend @ 15% for the year ended on June 30, 2013. Date of AGM: 20.11.2013, Time: 10:00 AM, Venue: Trust Milonayoton, 545, Old Airport Road, Tejgaon, Dhaka-1206. Record Date: 28.10.2013. The Company has also reported net profit of Tk. 77.84 million, EPS of Tk. 1.62, NAV per share of Tk. 12.24 and NOCFPS of Tk. 1.68 for the year ended on June 30, 2013.
- There will be no price limit on the trading of the shares of the Company today (10.10.2013) following its corporate decl
There will be no price limit on the trading of the shares of the Company today (10.10.2013) following its corporate declaration.
- As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will
As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on October 09, 2013 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2013.
- (Continuation of news of Central Pharmaceuticals -Q3): Whereas for the period of 9 (nine) months (July 2012 to March 201
(Continuation of news of Central Pharmaceuticals -Q3): Whereas for the period of 9 (nine) months (July 2012 to March 2013) ended on 31 March 2013 profit after tax was Tk. 38.63 million and basic EPS was Tk. 0.80 as against profit after tax of Tk. 12.92 million and basic EPS of Tk. 0.49 for the same period of the previous year. It is to be noted that the said EPS has been calculated based on weighted average Pre-IPO paid-up number of shares i.e. 48,000,000 shares for 2013 & 26,167,273 shares for 2012. However, considering Post-IPO 62,000,000 number of shares, Company's basic EPS would be Tk. 0.62 for 9 (nine) months ended on 31 March 2013 (July 2012 to March 2013) and NAV would be Tk. 11.61 as on 31 March 2013. (End)
The first part of this announcement is missing from the archive. - (Q3): (Repeat): The Company has reported its profit after tax Tk. 16.73 million and basic EPS Tk. 0.35 for the 3 (three)
(Q3): (Repeat): The Company has reported its profit after tax Tk. 16.73 million and basic EPS Tk. 0.35 for the 3 (three) months ended on 31 March 2013 (January 2013- March 2013) as against profit after tax of Tk. 9.11 million and basic EPS of Tk. 0.19 for the same period of the previous year. It is to be noted that basic EPS has been calculated based on weighted average Pre-IPO paid-up number of shares i.e. 48,000,000 shares for 2013 & 2012. However, considering Post-IPO 62,000,000 number of shares the Company's basic EPS for the 3 (three) months ended on 31 March 2013 would be Tk. 0.27. (cont.1)
- (Repeat): Trading of the shares of Central Pharmaceuticals Limited will commence today (August 14, 2013) at DSE under 'N
(Repeat): Trading of the shares of Central Pharmaceuticals Limited will commence today (August 14, 2013) at DSE under 'N' category. DSE Trading Code for Central Pharmaceuticals Limited is "CENTRALPHL" and DSE Company Code # 18488.
- Commences at DSE
Central Pharmaceuticals Limited: Trading of the shares of Central Pharmaceuticals Limited will commence at DSE from August 14, 2013 under 'N' category. DSE Trading Code for Central Pharmaceuticals Limited is "CENTRALPHL" and DSE Company Code # 18488.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.